Evidence map›Paper›PMID 36078042›Full record

ArticleCells2022

Identifying Disease Signatures in the Spinocerebellar Ataxia Type 1 Mouse Cortex.

Kimberly Luttik, Victor Olmos, Ashley Owens, Aryaan Khan, Joy Yun, Terri Driessen, Janghoo Lim

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kimberly LuttikInterdepartmental Neuroscience Program, Yale School of Medicine, New Haven, CT 06510, USA.ORCID 0000-0001-8642-6640
Victor OlmosDepartment of Genetics, Yale School of Medicine, New Haven, CT 06510, USA.
Ashley OwensInterdepartmental Neuroscience Program, Yale School of Medicine, New Haven, CT 06510, USA.
Aryaan KhanYale College, New Haven, CT 06510, USA.
Joy YunYale College, New Haven, CT 06510, USA.ORCID 0000-0002-3889-3284
Terri DriessenDepartment of Genetics, Yale School of Medicine, New Haven, CT 06510, USA.
Janghoo LimInterdepartmental Neuroscience Program, Yale School of Medicine, New Haven, CT 06510, USA.
Yale University · USYale Cancer Center · US

Funding

Interdepartmental Neuroscience Program (INP)T32NS041228 · NINDS · YALE UNIVERSITY · PI Charles A Greer, Marina R Picciotto · 2001 to 2026
$12.0M
GENETICS AND GENOMICS OF HUMAN DISEASET32HD007149 · NICHD · YALE UNIVERSITY · PI James P Noonan · 1985 to 2026
$8.2M
NEUROBIOLOGY OF CORTICAL SYSTEMST32NS007224 · NINDS · YALE UNIVERSITY · PI CARDIN, JESSICA A · 1985 to 2025
$4.6M
Evaluation of a novel NLK function in lysosome biogenesis and neurodegenerative diseasesR01AG074609 · NIA · YALE UNIVERSITY · PI LIM, JANGHOO · 2021 to 2025
$4.0M
Investigation of the role of ATXN1 in oligodendroglia and neurodegenerative diseasesR01AG076154 · NIA · YALE UNIVERSITY · PI Janghoo Lim · 2022 to 2026
$3.5M
Microglial regulation of Progranulin levelsR01AG066447 · NIA · YALE UNIVERSITY · PI LIM, JANGHOO · 2020 to 2024
$3.1M
Investigating the Pathogenesis of Cerebellar NeurodegenerationR01NS083706 · NINDS · YALE UNIVERSITY · PI LIM, JANGHOO · 2014 to 2018
$1.8M
NIA NIH HHS R01 AG066447NIA NIH HHS R01 AG074609NIA NIH HHS R01 AG076154NICHD NIH HHS T32 HD007149NINDS NIH HHS R01 NS083706NINDS NIH HHS T32 NS007224NINDS NIH HHS T32 NS041228
6 · The paper itself

Abstract

The neurodegenerative disease spinocerebellar ataxia type 1 (SCA1) is known to lead to the progressive degeneration of specific neuronal populations, including cerebellar Purkinje cells (PCs), brainstem cranial nerve nuclei and inferior olive nuclei, and spinocerebellar tracts. The disease-causing protein ataxin-1 is fairly ubiquitously expressed throughout the brain and spinal cord, but most studies have primarily focused on the role of ataxin-1 in the cerebellum and brainstem. Therefore, the functions of ataxin-1 and the effects of SCA1 mutations in other brain regions including the cortex are not well-known. Here, we characterized pathology in the motor cortex of a SCA1 mouse model and performed RNA sequencing in this brain region to investigate the impact of mutant ataxin-1 towards transcriptomic alterations. We identified progressive cortical pathology and significant transcriptomic changes in the motor cortex of a SCA1 mouse model. We also identified progressive, region-specific, colocalization of p62 protein with mutant ataxin-1 aggregates in broad brain regions, but not the cerebellum or brainstem. A cross-regional comparison of the SCA1 cortical and cerebellar transcriptomic changes identified both common and unique gene expression changes between the two regions, including shared synaptic dysfunction and region-specific kinase regulation. These findings suggest that the cortex is progressively impacted via both shared and region-specific mechanisms in SCA1.

Indexed as

Nerve Tissue ProteinsSpinocerebellar AtaxiasAnimalsAtaxin-1Disease Models, AnimalMiceMice, TransgenicPurkinje CellsAtaxin-1Atxn1 protein, mouseNerve Tissue Proteinscortexneurodegenerationregional vulnerabilitySCA1spinocerebellar ataxia type 1

Identifiers

PMID36078042
PMCPMC9454518
OpenAlexW4293008889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.